![](/img/cover-not-exists.png)
A phase 1b trial of lenvatinib (LEN) plus pembrolizumab (PEM) in patients with selected solid tumors
Taylor, M., Dutcus, C.E., Schmidt, E., Bagulho, T., Li, D., Shumaker, R., Rasco, D.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw373.04
Date:
October, 2016
File:
PDF, 40 KB
english, 2016